New vaccine study aims to shield toddlers from deadly meningitis
NCT ID NCT05935176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a vaccine designed to protect young children from four types of meningitis bacteria. Researchers gave the vaccine to 660 toddlers aged 6 to 23 months and will check their immune response over time. Some children will also receive a booster shot at age 3 to see if protection lasts longer. The goal is to confirm the vaccine works well and is safe for this age group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDEMIC MENINGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wuzhi County Center for Disease Control and Prevention
Jiaozuo, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new vaccine safely shield babies from meningitis?
- Could a single meningitis shot protect for years? a study investigates
- New meningitis vaccine for kids shows promise in large trial
- New meningitis vaccine trial aims to shield babies from deadly infection
- New meningitis vaccine trial aims to protect babies
- New meningitis vaccine for toddlers shows promise in major trial